Below is Validea's guru fundamental report for LINDE PLC (LIN). Of the 22 guru strategies we follow, LIN rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to ear
Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that e
Below is Validea's guru fundamental report for SNOWFLAKE INC (SNOW). Of the 22 guru strategies we follow, SNOW rates highest using our Twin Momentum Investor model based on the published strategy of Dashan Huang. This momentum model looks for a combination of fundamental momentu
Below is Validea's guru fundamental report for WELLS FARGO & CO (WFC). Of the 22 guru strategies we follow, WFC rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks low volatility stocks that also
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks low volatility stocks that also h
Below is Validea's guru fundamental report for PEPSICO INC (PEP). Of the 22 guru strategies we follow, PEP rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit cha
(RTTNews) - European stocks are seen opening slightly lower on Wednesday in the lead up to the Federal Reserve's highly anticipated monetary policy announcement later in the day.
(RTTNews) - Super Micro Computer, Inc. (SMCI) announced that it has priced underwritten public offering of 2 million common shares at $875.00 per share. The company expects to close the offering on or about March 22, 2024.
(RTTNews) - Indian shares were slightly higher in cautious trade on Wednesday as investors eagerly await the Federal Reserve's interest rate decision and the dot plot projections later in the day.
(RTTNews) - Asian stock markets are trading mostly higher on Wednesday, following the broadly positive cues from global markets overnight, as traders reacted to monetary policy announcements from the Bank of Japan, People's Bank of China and the Reserve Bank of Australia. They ar
(RTTNews) - Nasdaq Inc. (NDAQ) announced the pricing of secondary offering by Borse Dubai of about 26.96 million shares of Nasdaq's common stock at $59.00 per share.
(RTTNews) - The Thai stock market has moved lower in three straight sessions, slipping more than a dozen points or 0.9 percent along the way. The Stock Exchange of Thailand now sits just above the 1,380-point plateau although it's due for support on Wednesday.
(RTTNews) - Amcor (AMCR, AMC.AX) said that after nine years as Chief Executive Officer, Ron Delia has informed the Board of Directors of his decision to retire from the company and step down from the Board for health reasons, effective April 15, 2024.
(RTTNews) - Japan's Takeda Pharmaceutical Co. Ltd. (TAK) said that the U.S. Food and Drug Administration approved the supplemental New Drug Application or sNDA for Iclusig (ponatinib) for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive acute
(RTTNews) - Australian shares are trading modestly higher on Wednesday, adding to the gains in the previous two sessions, with the benchmark S&P/ASX 200 staying above the 7,700 level, following the broadly positive cues from global markets overnight, with gains in iron ore miners
(RTTNews) - The Indonesia stock market on Tuesday ended the two-day slide in which it had slipped more than 30 points or 0.4 percent. The Jakarta Composite Index now sits just above the 7,335-point plateau and it's expected to open in the green again on Wednesday.
(RTTNews) - McDonald's Corp. (MCD) announced the retirement of Enrique "Rick" Hernandez, Jr. as non-executive Chairman of the company's Board of Directors, effective as of the date of the Company's 2024 Annual Shareholders' Meeting.
(RTTNews) - The Singapore Health Sciences Authority has approved Nefegan for the treatment of primary immunoglobulin A nephropathy or IgAN in adults at risk of disease progression, Everest Medicines said in a statement.